This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With Chinese swimmers getting 200 drug tests over 10 days ahead of the Paris Olympics, all eyes are on the World Anti-Doping Agency (WADA). Anti-doping is being politicized and some important questions are being asked with this Chinese fiasco. We believe an important question is this: Do performance-enhancing drugs actually work, or are they just placebos?
Analysis suggests extent of problem UN estimates is causing 500,000 deaths a year in sub-Saharan region A fifth of medicines in Africa could be substandard or fake, according to a major research project, raising the alarm over a problem that could be contributing to the deaths of countless patients. Researchers from Bahir Dar University in Ethiopia analysed 27 studies in the review and found, of the 7,508 medicine samples included, 1,639 failed at least one quality test and were confirmed to be
Carbamazepine auto-induction is a popular Board Exam question and is a term I learned in pharmacy school but I never remember being taught what that means clinically and how to monitor the auto-induction period effectively. Indications Matter I want to discuss indications first and foremost. There are recommended drug concentrations when carbamazepine is being used […] The post Carbamazepine Auto-Induction And What To Do About It appeared first on Med Ed 101.
DIA , a global organisation of life sciences professionals, will facilitate a series of discussions on the evolving regulatory landscape in India, the transformative power of digitisation in healthcare, and how to prioritise patient safety during the DIA India Annual Meeting , which will be held September 24 and 25 at Novotel Mumbai Juhu Beach. This year’s theme, “Confluence of Care,” focuses on the need for widespread cooperation and deliberation to drive the safe and effectiv
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Poll reveals emergency contraception, free prescription deliveries and extended opening hours among services hit Pharmacies across England are unable to provide critical NHS and public health services owing to the overwhelming financial and operational pressures they are facing, according to research. A poll of pharmacy owners representing more than 2,100 pharmacies found that more than 96% of respondents said they had stopped providing locally commissioned services over the past 12 months.
An FDA advisory committee has recommended approval of Zevra Therapeutics' arimoclomol for the ultra-rare disorder Niemann-Pick disease, three years after the regulator rejected the drug.The Genetic Metabolic Diseases Advisory Committee (GeMDAC) voted 11 to five that the data support the approval of the drug for Niemann-Pick disease type C (NPC), a progressive genetic disorder that leads to the accumulation of fatty substances in tissues and can cause a range of symptoms, including liver and lung
85
85
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
An FDA advisory committee has recommended approval of Zevra Therapeutics' arimoclomol for the ultra-rare disorder Niemann-Pick disease, three years after the regulator rejected the drug.The Genetic Metabolic Diseases Advisory Committee (GeMDAC) voted 11 to five that the data support the approval of the drug for Niemann-Pick disease type C (NPC), a progressive genetic disorder that leads to the accumulation of fatty substances in tissues and can cause a range of symptoms, including liver and lung
Daniel Galbraith, Chief Scientific Officer (CSO) of Solvias provided a comprehensive picture to Pharmaceutical Technology of the current landscape of cell and gene therapy advancements. The discussion covers important regulatory guidance, technological landmarks, and how Solvias is impacting the current market.
In this episode, I’ll discuss how the use of dopamine for shock affects mortality rates. Episode 945: How does the use of dopamine for shock affect mortality rates? Subscribe on iTunes , Android , or Stitcher Surviving Sepsis Guidelines do not list dopamine as one of the vasopressors to use for the treatment of septic shock, and other types of shock are usually treated with non-dopamine vasopressors as well due to the higher rate of ventricular arrhythmias associated with dopamine use.
Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim a
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content